Effects of anti-IgE [immunoglobulin E] antibody omalizumab (Xolair) on patients with chronic sinusitis and a positive allergen test.
Latest Information Update: 25 Nov 2014
At a glance
- Drugs Omalizumab (Primary)
- Indications Sinusitis
- Focus Therapeutic Use
- 13 Apr 2012 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 13 Apr 2012 Actual end date (Jan 2009) added as reported by ClinicalTrials.gov.
- 13 Apr 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.